The global eczema therapeutics market is anticipated to witness high growth due to an increasing incidence of atopic dermatitis across the world. Eczema therapeutics are medications prescribed for treating inflammatory skin conditions such as atopic dermatitis. The most common form of eczema is atopic dermatitis, which causes red, itchy rashes on the face, knees, elbows, and other parts of the body. The increasing prevalence of atopic dermatitis in both children and adults has raised the ... Read more

The global eczema therapeutics market is characterized by the presence of several players offering a varied range of treatment drugs and therapies including corticosteroids, calcineurin inhibitors, PDE-4 inhibitors, biologics, and antihistamines. These therapies are used for the treatment of eczema conditions such as atopic dermatitis and contact dermatitis. Eczema is a chronic, inflammatory skin disease that mainly affects children but can persist into adulthood. The global rise in eczema ... Read more